Page last updated: 2024-08-26

peptide elongation factor 2 and Acute Lymphoid Leukemia

peptide elongation factor 2 has been researched along with Acute Lymphoid Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bera, TK; Chertov, O; FitzGerald, DJ; Pastan, I; Wayne, AS; Wei, H; Xiang, L	1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and Acute Lymphoid Leukemia

Article	Year
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy. Proceedings of the National Academy of Sciences of the United States of America, 2012, May-01, Volume: 109, Issue:18 Topics: Azacitidine; Bacterial Toxins; Base Sequence; Cell Line, Tumor; CpG Islands; DNA Methylation; DNA, Neoplasm; Drug Resistance, Neoplasm; Exotoxins; HSP40 Heat-Shock Proteins; Humans; Immunotoxins; Molecular Sequence Data; Peptide Elongation Factor 2; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Sialic Acid Binding Ig-like Lectin 2	2012

Article

Year

Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy.

Proceedings of the National Academy of Sciences of the United States of America, 2012, May-01, Volume: 109, Issue:18

Topics: Azacitidine; Bacterial Toxins; Base Sequence; Cell Line, Tumor; CpG Islands; DNA Methylation; DNA, Neoplasm; Drug Resistance, Neoplasm; Exotoxins; HSP40 Heat-Shock Proteins; Humans; Immunotoxins; Molecular Sequence Data; Peptide Elongation Factor 2; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Sialic Acid Binding Ig-like Lectin 2

2012